Resveratrol rescues TNF‑α‑induced inhibition of osteogenesis in human periodontal ligament stem cells via the ERK1/2 pathway

Yuan,Jiakan; Wang,Xuxia; Ma,Dan; Gao,Hui; Zheng,Dehua; Zhang,Jun

doi:10.3892/mmr.2020.11021

Resveratrol rescues TNF‑α‑induced inhibition of osteogenesis in human periodontal ligament stem cells via the ERK1/2 pathway

Authors:
- Jiakan Yuan
- Xuxia Wang
- Dan Ma
- Hui Gao
- Dehua Zheng
- Jun Zhang
View Affiliations

Affiliations: Shandong Provincial Key Laboratory of Oral Tissue Regeneration & Shandong Engineering Laboratory for Dental Materials and Oral Tissue Regeneration, Jinan, Shandong 250012, P.R. China
Published online on: March 11, 2020 https://doi.org/10.3892/mmr.2020.11021
Pages: 2085-2094
Copyright: © Yuan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Periodontitis is a common inflammatory disorder affecting the tissues surrounding the teeth, which can lead to the destruction of periodontal tissue and tooth loss. Resveratrol, a natural phytoalexin, exerts multiple biological effects. For example, its anti‑inflammatory activity has been widely studied for the treatment of inflammatory bowel disease for a number of years. However, its effect on bone repair and new bone formation in an inflammatory microenvironment is not well understood. Accordingly, the effect of resveratrol on inflammation‑affected human periodontal ligament stem cells (hPDLSCs) requires further investigation. In the present study, the effect of tumor necrosis factor‑α (TNF‑α), resveratrol, or the combination of both on the osteogenic differentiation of hPDLSCs, as well as the underlying mechanisms involved, were investigated. Cell Counting Kit‑8 assay, alkaline phosphatase staining, Alizarin red staining, Oil Red O staining, reverse transcription‑quantitative PCR and western blotting were used in the present study. It was demonstrated that resveratrol enhanced hPDLSC osteogenesis and reversed the inhibitory effects of TNF‑α on this process. Further mechanistic studies indicated that resveratrol exerted anti‑inflammatory activity by activating the ERK1/2 pathway, decreasing the secretion of interleukin (IL)‑6 and IL‑8 induced by TNF‑α, and enhancing hPDLSCs osteogenesis. The present study suggested that resveratrol may be a novel and promising therapeutic choice for periodontitis.

View Figures

View References

1	Chen FM, Zhang J, Zhang M, An Y, Chen F and Wu ZF: A review on endogenous regenerative technology in periodontal regenerative medicine. Biomaterials. 31:7892–7927. 2010. View Article : Google Scholar : PubMed/NCBI
2	Han J, Menicanin D, Gronthos S and Bartold PM: Stem cells, tissue engineering and periodontal regeneration. Aust Dent J. 59 (Suppl 1):S117–S130. 2014. View Article : Google Scholar
3	Seo BM, Miura M, Gronthos S, Bartold PM, Batouli S, Brahim J, Young M, Robey PG, Wang CY and Shi S: Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet. 364:149–155. 2004. View Article : Google Scholar : PubMed/NCBI
4	Lindsay R and Tohme JF: Estrogen treatment of patients with established postmenopausal osteoporosis. Obstet Gynecol. 76:290–295. 1990.PubMed/NCBI
5	Zaidi M: Skeletal remodeling in health and disease. Nat Med. 13:791–801. 2007. View Article : Google Scholar : PubMed/NCBI
6	Falahati-Nini A, Riggs BL, Atkinson EJ, O'Fallon WM, Eastell R and Khosla S: Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest. 106:1553–1560. 2000. View Article : Google Scholar : PubMed/NCBI
7	Lampe J and Messina M: Are phytoestrogens nature's cure for what ails us? A look at the research. Interview by Nancy I. Hahn. J Am Diet Assoc. 98:974–976. 1998. View Article : Google Scholar : PubMed/NCBI
8	Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, et al: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 275:218–210. 1997. View Article : Google Scholar : PubMed/NCBI
9	Gehm BD, McAndrews JM, Chien PY and Jameson JL: Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA. 94:14138–14143. 1997. View Article : Google Scholar : PubMed/NCBI
10	Hao XD, Chang J, Qin BY, Zhong C, Chu ZB, Huang J, Zhou WJ and Sun X: Synthesis, estrogenic activity, and anti-osteoporosis effects in ovariectomized rats of resveratrol oligomer derivatives. Eur J Med Chem. 102:26–38. 2015. View Article : Google Scholar : PubMed/NCBI
11	Savouret JF and Quesne M: Resveratrol and cancer: A review. Biomed Pharmacother. 56:84–87. 2002. View Article : Google Scholar : PubMed/NCBI
12	Cao Z and Li Y: Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: Protection against oxidative and electrophilic injury. Eur J Pharmacol. 489:39–48. 2004. View Article : Google Scholar : PubMed/NCBI
13	Gómez-Zorita S, Fernández-Quintela A, Lasa A, Hijona E, Bujanda L and Portillo MP: Effects of resveratrol on obesity-related inflammation markers in adipose tissue of genetically obese rats. Nutrition. 29:1374–1380. 2013. View Article : Google Scholar : PubMed/NCBI
14	Ornstrup MJ, Harsløf T, Kjær TN, Langdahl BL and Pedersen SB: Resveratrol increases bone mineral density and bone alkaline phosphatase in obese men: A randomized placebo-controlled trial. J Clin Endocrinol Metab. 99:4720–4729. 2014. View Article : Google Scholar : PubMed/NCBI
15	Bo S, Gambino R, Ponzo V, Cioffi I, Goitre I, Evangelista A, Ciccone G, Cassader M and Procopio M: Effects of resveratrol on bone health in type 2 diabetic patients. A double-blind randomized-controlled trial. Nutr Diabetes. 8:512018. View Article : Google Scholar : PubMed/NCBI
16	Mizutani K, Ikeda K, Kawai Y and Yamori Y: Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells. Biochem Biophys Res Commun. 253:859–863. 1998. View Article : Google Scholar : PubMed/NCBI
17	Dai Z, Li Y, Quarles LD, Song T, Pan W, Zhou H and Xiao Z: Resveratrol enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via ER-dependent ERK1/2 activation. Phytomedicine. 14:806–814. 2007. View Article : Google Scholar : PubMed/NCBI
18	Tseng PC, Hou SM, Chen RJ, Peng HW, Hsieh CF, Kuo ML and Yen ML: Resveratrol promotes osteogenesis of human mesenchymal stem cells by upregulating Runx2 gene expression via the SIRT1/FOXO3A axis. J Bone Miner Res. 26:2552–2563. 2011. View Article : Google Scholar : PubMed/NCBI
19	Kwan Tat S, Padrines M, Théoleyre S, Heymann D and Fortun Y: IL-6, RANKL, TNF-alpha/IL-1: Interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev. 15:49–60. 2004. View Article : Google Scholar : PubMed/NCBI
20	Brennan FM, Maini RN and Feldmann M: TNF alpha-a pivotal role in rheumatoid arthritis? Br J Rheumatol. 31:293–298. 1992. View Article : Google Scholar : PubMed/NCBI
21	Bartold PM, Cantley MD and Haynes DR: Mechanisms and control of pathologic bone loss in periodontitis. Periodontol. 2000(53): 55–69. 2010. View Article : Google Scholar
22	Digirolamo CM, Stokes D, Colter D, Phinney DG, Class R and Prockop DJ: Propagation and senescence of human marrow stromal cells in culture: A simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol. 107:275–281. 1999. View Article : Google Scholar : PubMed/NCBI
23	Du L, Yang P and Ge S: Stromal cell-derived factor-1 significantly induces proliferation, migration, and collagen type I expression in a human periodontal ligament stem cell subpopulation. J Periodontol. 83:379–388. 2012. View Article : Google Scholar : PubMed/NCBI
24	Shigetani Y, Ohkura N, Yoshiba K, Ohshima H, Hosoya A, Yoshiba A and Okiji T: GaAlAs laser-induced pulp mineralization involves dentin matrix protein 1 and osteopontin expression. Oral Dis. 22:399–405. 2016. View Article : Google Scholar : PubMed/NCBI
25	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
26	Simmons CA, Matlis S, Thornton AJ, Chen S, Wang CY and Mooney DJ: Cyclic strain enhances matrix mineralization by adult human mesenchymal stem cells via the extracellular signal-regulated kinase (ERK1/2) signaling pathway. J Biomech. 36:1087–1096. 2003. View Article : Google Scholar : PubMed/NCBI
27	Alessi DR, Cuenda A, Cohen P, Dudley DT and Saltiel AR: PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem. 270:27489–27494. 1995. View Article : Google Scholar : PubMed/NCBI
28	Gehart H, Kumpf S, Ittner A and Ricci R: MAPK signalling in cellular metabolism: Stress or wellness? EMBO Rep. 11:834–840. 2010. View Article : Google Scholar : PubMed/NCBI
29	Roy SK, Srivastava RK and Shankar S: Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer. J Mol Signal. 5:102010. View Article : Google Scholar : PubMed/NCBI
30	Page RC: The pathobiology of periodontal diseases may affect systemic diseases: Inversion of a paradigm. Ann Periodontol. 3:108–120. 1998. View Article : Google Scholar : PubMed/NCBI
31	Galler KM and D'Souza RN: Tissue engineering approaches for regenerative dentistry. Regen Med. 6:111–124. 2011. View Article : Google Scholar : PubMed/NCBI
32	Beutler B, Greenwald D, Hulmes JD, Chang M, Pan YC, Mathison J, Ulevitch R and Cerami A: Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature. 316:552–554. 1985. View Article : Google Scholar : PubMed/NCBI
33	Suffredini AF, Reda D, Banks SM, Tropea M, Agosti JM and Miller R: Effects of recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administration. J Immunol. 155:5038–5045. 1995.PubMed/NCBI
34	Brunetti G, Colucci S, Pignataro P, Coricciati M, Mori G, Cirulli N, Zallone A, Grassi FR and Grano M: T cells support osteoclastogenesis in an in vitro model derived from human periodontitis patients. J Periodontol. 76:1675–1680. 2005. View Article : Google Scholar : PubMed/NCBI
35	Gilbert L, He X, Farmer P, Boden S, Kozlowski M, Rubin J and Nanes MS: Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology. 141:3956–3964. 2000. View Article : Google Scholar : PubMed/NCBI
36	Lacey DC, Simmons PJ, Graves SE and Hamilton JA: Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: Implications for bone repair during inflammation. Osteoarthritis Cartilage. 17:735–742. 2009. View Article : Google Scholar : PubMed/NCBI
37	Feng X, Feng G, Xing J, Shen B, Li L, Tan W, Xu Y, Liu S, Liu H, Jiang J, et al: TNF-α triggers osteogenic differentiation of human dental pulp stem cells via the NF-κB signalling pathway. Cell Biol Int. 37:1267–1275. 2013. View Article : Google Scholar : PubMed/NCBI
38	Huang H, Zhao N, Xu X, Xu Y, Li S, Zhang J and Yang P: Dose-specific effects of tumor necrosis factor alpha on osteogenic differentiation of mesenchymal stem cells. Cell Prolif. 44:420–427. 2011. View Article : Google Scholar : PubMed/NCBI
39	Lu Z, Wang G, Dunstan CR and Zreiqat H: Short-term exposure to tumor necrosis factor-alpha enables human osteoblasts to direct adipose tissue-derived mesenchymal stem cells into osteogenic differentiation. Stem Cells Dev. 21:2420–2429. 2012. View Article : Google Scholar : PubMed/NCBI
40	Gorbunov N, Petrovski G, Gurusamy N, Ray D, Kim DH and Das DK: Regeneration of infarcted myocardium with resveratrol-modified cardiac stem cells. J Cell Mol Med. 16:174–184. 2012. View Article : Google Scholar : PubMed/NCBI
41	Zhu X, Liu Q, Wang M, Liang M, Yang X, Xu X, Zou H and Qiu J: Activation of Sirt1 by resveratrol inhibits TNF-α induced inflammation in fibroblasts. PLoS One. 6:e270812011. View Article : Google Scholar : PubMed/NCBI
42	Bertelli AA, Baccalini R, Battaglia E, Falchi M and Ferrero ME: Resveratrol inhibits TNF alpha-induced endothelial cell activation. Therapie. 56:613–616. 2001.PubMed/NCBI
43	Song LH, Pan W, Yu YH, Quarles LD, Zhou HH and Xiao ZS: Resveratrol prevents CsA inhibition of proliferation and osteoblastic differentiation of mouse bone marrow-derived mesenchymal stem cells through an ER/NO/cGMP pathway. Toxicol In Vitro. 20:915–922. 2006. View Article : Google Scholar : PubMed/NCBI
44	Boissy P, Andersen TL, Abdallah BM, Kassem M, Plesner T and Delaissé JM: Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation. Cancer Res. 65:9943–9952. 2005. View Article : Google Scholar : PubMed/NCBI
45	Durbin SM, Jackson JR, Ryan MJ, Gigliotti JC, Alway SE and Tou JC: Resveratrol supplementation preserves long bone mass, microstructure, and strength in hindlimb-suspended old male rats. J Bone Miner Metab. 32:38–47. 2014. View Article : Google Scholar : PubMed/NCBI
46	Liu ZP, Li WX, Yu B, Huang J, Sun J, Huo JS and Liu CX: Effects of trans-resveratrol from Polygonum cuspidatum on bone loss using the ovariectomized rat model. J Med Food. 8:14–19. 2005. View Article : Google Scholar : PubMed/NCBI
47	Zhao H, Li X, Li N, Liu T, Liu J, Li Z, Xiao H and Li J: Long-term resveratrol treatment prevents ovariectomy-induced osteopenia in rats without hyperplastic effects on the uterus. Br J Nutr. 111:836–846. 2014. View Article : Google Scholar : PubMed/NCBI
48	Zhou H, Shang L, Li X, Zhang X, Gao G, Guo C, Chen B, Liu Q, Gong Y and Shao C: Resveratrol augments the canonical Wnt signaling pathway in promoting osteoblastic differentiation of multipotent mesenchymal cells. Exp Cell Res. 315:2953–2962. 2009. View Article : Google Scholar : PubMed/NCBI
49	Uguralp S, Irsi C, Aksoy T, Karabulut AB, Kirimlioglu H and Mizrak B: Resveratrol attenuates inflammation and stricture formation in experimental caustic esophageal burns. Pediatr Surg Int. 24:425–430. 2008. View Article : Google Scholar : PubMed/NCBI
50	Bereswill S, Muñoz M, Fischer A, Plickert R, Haag LM, Otto B, Kühl AA, Loddenkemper C, Göbel UB and Heimesaat MM: Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation. PLoS One. 5:e150992010. View Article : Google Scholar : PubMed/NCBI
51	Larrosa M, Yañéz-Gascón MJ, Selma MV, González-Sarrías A, Toti S, Cerón JJ, Tomás-Barberán F, Dolara P and Espín JC: Effect of a low dose of dietary resveratrol on colon microbiota, inflammation and tissue damage in a DSS-induced colitis rat model. J Agric Food Chem. 57:2211–2220. 2009. View Article : Google Scholar : PubMed/NCBI